The online version of this article (doi:10.1186/s12885-017-3172-1) contains supplementary material, which is available to authorized users.
Approximately one third of cancer survivors in the United Kingdom face ongoing and debilitating psychological and physical symptoms related to poor quality of life. Very little is known about current post-cancer treatment services.
Oncology healthcare professionals (HCPs) were invited to take part in a survey, which gathered both quantitative and free text data about the content and delivery of cancer aftercare and patient needs. Analysis involved descriptive statistics and content analysis.
There were 163 complete responses from 278 survey participants; 70% of NHS acute trusts provided data. HCPs views on patient post-cancer treatment needs were most frequently: fear of recurrence (95%), fatigue (94%), changes in physical capabilities (89%), anxiety (89%) and depression (88%). A median number of 2 aftercare sessions were provided (interquartile range: 1,4) lasting between 30 and 60 min. Usually these were provided face-to-face and intermittently by a HCP. However, sessions did not necessarily address the issues HCPs asserted as important. Themes from free-text responses highlighted inconsistencies in care, uncertain funding for services and omission of some evidence based approaches.
Provision of post-cancer treatment follow-up care is neither universal nor consistent in the NHS, nor does it address needs HCPs identified as most important.
Additional file 1: SUrvivors Rehabilitation Evaluation after Cancer (SURECAN). (PDF 462 kb)12885_2017_3172_MOESM1_ESM.pdf
Quality of Life of Cancer Survivors in England: Report on a pilot survey using Patient Reported Outcome Measures (PROMS). https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/267042/9284-TSO-2900701-PROMS-1.pdf. Accessed 21 May 2016.
Fors EA, Bertheussen GF, Thune I, Juvet LK, Elvsaas IK, Oldervoll L, Anker G, Falkmer U, Lundgren S, Leivseth G. Psychosocial interventions as part of breast cancer rehabilitation programs? results from a systematic review. Psychooncology. 2011;20(9):909–18. PubMed
Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, Snyder C. Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev. 2012;8:CD007566.
Bourke L, Smith D, Steed L, Hooper R, Carter A, Catto J, Albertsen PC, Tombal B, Payne HA, Rosario DJ. Exercise for Men with prostate cancer: a systematic review and meta-analysis. Eur Urol. 2015;69(64):693–703. PubMed
Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;8:CD008465.
Nilsson MI, Saboonchi F, Alexanderson K, Olsson M, Wennman-Larsen A, Petersson LM: Changes in importance of work and vocational satisfaction during the 2 years after breast cancer surgery and factors associated with this. J Cancer Surviv. 2016;10(3):564–72.
Ritchie J, Spencer L. Qualitative data analysis for applied policy research. London: Routledge; 1994. CrossRef
Improving outcomes: a strategy for cancer. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213785/dh_123394.pdf. Accessed 21 May 2016.
ACHIEVING WORLD-CLASS CANCER OUTCOMES A STRATEGY FOR ENGLAND 2015-2020. https://www.cancerresearchuk.org/sites/default/files/achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020.pdf. Accesed 21 May 2016.
Improving cancer outcomes: An analysis of the implementation of the UK’s cancer strategies 2006-2010. Accessed at http://www.cancerresearchuk.org/sites/default/files/policy-improving-cancer-outcomes-uk-cancer-strategy-2006-2010.pdf. Accessed 5 Jan 2016.
The Recovery Package. http://www.macmillan.org.uk/aboutus/healthandsocialcareprofessionals/macmillansprogrammesandservices/recoverypackage/recoverypackage.aspx. Accessed 21 May 2016.
- A survey to determine usual care after cancer treatment within the United Kingdom national health service
P. D. White
K. S. Bhui
M. A. Thaha
on behalf of the SURECAN investigators
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II